Medical Health & Life Science Research News

Asia-Pacific melanoma therapeutics market to be growing at a CAGR of $1.24 billion by 2021 according to new research report

Asia-Pacific melanoma therapeutics market to be growing at a CAGR of $1.24 billion by 2021 according to new research report

Asia-Pacific Melanoma Therapeutics Market was worth $0.58 billion in 2016 and estimated to be growing at a CAGR of 16.40%, to reach $1.24 billion by 2021.

- Advertising -

The melanoma market has seen an unparalleled boost in market size, owing to a vigorously developing nature of melanoma treatments over the recent past.

The elevated demand of innovative early stage and advanced melanoma treatments along with a thriving patient base, has generated an imminent need for improved therapies in the melanoma market. Even though, a plethora of treatment choices are accessible today, various immunotherapies and combination therapies are anticipated to arrive in the market.

Large acceptance of these new treatments is projected due to their enhanced survival benefits and negligible side effects.

- Advertising -

Browse market data tables and in-depth TOC of the Asia-Pacific Melanoma Therapeutics Market to 2021 at www.marketdataforecast.com/market-…utics-market-854/

The growth of the Asia-Pacific Melanoma Therapeutics market is mainly due to factors such as rise in number of melanoma cases, and growing awareness towards it. However, volatile economies and poor accessibility of proper cancer care in this part of the world are the key factors hindering the growth of the market in this region.

Report: www.marketdataforecast.com/market-…54/request-sample

The Asia-Pacific Melanoma Therapeutics market is segmented based on cancer stage, cancer type, diagnosis, and treatment. The market for Melanoma Therapeutics, on the basis of cancer stage is segmented into Stage 0, Stage I, Stage II, Stage III, Stage IV.

On the basis of cancer type, the Melanoma Therapeutics market is segmented into Nodular melanoma, Acral lentiginous melanoma, Superficial spreading melanoma, Lentigno maligna melanoma, Amelanotic melanoma, and Others. On the basis of diagnosis, the Melanoma Therapeutics market is segmented into Ultrasound, Blood Tests, Dermatoscopy, Sentinel lymph node biopsy, X-rays, CT Scan.

On the basis of treatment, the Melanoma Therapeutics market is segmented into early melanoma and advanced melanoma. Advanced melanoma is further sub-segmented into Biological therapy, Targeted therapy, Surgery, Chemotherapy, Radiotherapy, Immune therapy.

X-rays leads the Melanoma Therapeutics market under the diagnosis segment, whereas chemotherapy leads the market under the treatment segment.

Report: www.marketdataforecast.com/market-…arket-854/inquire

The Asia-Pacific Melanoma Therapeutics market is geographically segmented into China, India, Japan, South Korea, and Australia. The Asia-Pacific Melanoma Therapeutics market is projected to grow at the highest CAGR during the forecast period due to reasons such as large population base and rising prevalence of melanoma.

China is the largest market for Melanoma Therapeutics in this region followed by India.

The major companies dominating the market in this region are Bristol-Myers Squibb Co., Merck and Co., F. Hoffmann-La Roche, Amgen Inc., Celgene Corp, Daiichi Sankyo, and Pfizer Inc.

 

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...